title: Restoration of C/EBPα in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosis.
abstract: Well-differentiated liposarcoma (WDLS) and dedifferentiated liposarcoma (DDLS) represent the most common biological group of liposarcoma, and there is a pressing need to develop targeted therapies for patients with advanced disease. To identify potential therapeutic targets, we sought to identify differences in the adipogenic pathways between DDLS, WDLS, and normal adipose tissue. In a microarray analysis of DDLS (n = 84), WDLS (n = 79), and normal fat (n = 23), C/EBPα, a transcription factor involved in cell cycle regulation and differentiation, was underexpressed in DDLS when compared to both WDLS and normal fat (15.2- and 27.8-fold, respectively). In normal adipose-derived stem cells, C/EBPα expression was strongly induced when cells were cultured in differentiation media, but in three DDLS cell lines, this induction was nearly absent. We restored C/EBPα expression in one of the cell lines (DDLS8817) by transfection of an inducible C/EBPα expression vector. Inducing C/EBPα expression reduced proliferation and caused cells to accumulate in G2/M. Under differentiation conditions, the cell proliferation was reduced further, and 66% of the DDLS cells containing the inducible C/EBPα expression vector underwent apoptosis as demonstrated by annexin V staining. These cells in differentiation conditions expressed early adipocyte-specific mRNAs such as LPL and FABP4, but they failed to accumulate intracellular lipid droplets, a characteristic of mature adipocytes. These results demonstrate that loss of C/EBPα is an important factor in suppressing apoptosis and maintaining the dedifferentiated state in DDLS. Restoring C/EBPα may be a useful therapeutic approach for DDLS.
authors.affiliation: Sarcoma Biology Laboratory, Sarcoma Disease Management Program, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
authors.forename: Yuhsin V
authors.initials: YV
authors.lastname: Wu
authors.forename: Tomoyo
authors.initials: T
authors.lastname: Okada
authors.forename: Penelope
authors.initials: P
authors.lastname: DeCarolis
authors.forename: Nicholas
authors.initials: N
authors.lastname: Socci
authors.forename: Rachael
authors.initials: R
authors.lastname: O'Connor
authors.forename: Rula C
authors.initials: RC
authors.lastname: Geha
authors.forename: C
authors.initials: C
authors.lastname: Joy Somberg
authors.forename: Cristina
authors.initials: C
authors.lastname: Antonescu
authors.forename: Samuel
authors.initials: S
authors.lastname: Singer
mesh_terms: D017667:Adipocytes / Q000166:cytology / Q000378:metabolism; D000273:Adipose Tissue / Q000378:metabolism; D017209:Apoptosis; D022763:CCAAT-Enhancer-Binding Protein-alpha / Q000235:genetics / Q000378:metabolism*; D002453:Cell Cycle; D002454:Cell Differentiation; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D059565:G2 Phase Cell Cycle Checkpoints; D006801:Humans; D008055:Lipids / Q000096:biosynthesis; D008080:Liposarcoma / Q000378:metabolism* / Q000473:pathology*; D018205:Neoplasms, Adipose Tissue; D047495:PPAR gamma / Q000037:antagonists & inhibitors / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis; D015398:Signal Transduction; D013234:Stem Cells / Q000378:metabolism
chemical_list: D022763:CCAAT-Enhancer-Binding Protein-alpha; D008055:Lipids; D047495:PPAR gamma; D012333:RNA, Messenger